There are no Focus articles on DGCRF.
There are no Related articles on DGCRF.
There are no Transcripts on DGCRF.
May. 15, 2013, 3:22 PMGene-related stocks are getting a big bump today on the back of Angelina Jolie's recent decision to have a mastectomy to prevent possible breast cancer: Rosetta Genomics (ROSG +15.5%), Genetic Technologies (GENE +12.9%), Diagnocure (DGCRF.PK +12%), GeneNews (GNSWF.PK +5%). Myriad Genetics (MYGN -2.2%) is lower on a bout of profit-taking, possibly exacerbated by news of some insider selling today by its CEO as well. | Comment!
There are no StockTalks on this stock yet.
DGCRF vs. ETF Alternatives
DiagnoCure Inc. is a life sciences corporation that develops and commercializes high-value cancer diagnostic test that increases clinician and patient confidence in making critical treatment decisions. The corporation has granted a worldwide exclusive license agreement to Gen-Probe, now a... More
Other News & PR